Ionis Pharmaceuticals | IONS - Ebitda





Ebitda 更改 日
Agios Pharmaceuticals USD -120.31M 4.82M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Arrowhead Research USD 57.17M 7.03M 2025-12
Astellas Pharma JPY 98.93B 84.75B 2026-03
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Celltrion KRW 17.79B 356.77B 2025-12
Cspc Pharmaceutical CNY 2.19B 21.88M 2024-12
Deva Holding AS TRY 882.9M 201.7M 2023-09
Divis Laboratories Ltd INR 9.34B 440M 2026-03
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Exelixis USD 258.29M 15.43M 2026-03
Halozyme Therapeutics USD 219.57M 197.66M 2026-03
Ionis Pharmaceuticals USD -200.02M 42.89M 2025-12
Kangmei Pharma CNY -12.72M 30.02M 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Laboratorios Farma EUR 34.94M 102.95M 2025-06
Malin Corporation EUR -1.1M 200K 2024-12
Medical Developments International AUD 1.78M 3.78M 2024-12
Moderna USD -790M 582M 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Neuren Pharmaceuticals AUD 11.14M 165.56M 2025-12
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 5.3B 530M 2026-03
Omeros USD -47.96M 7.39M 2023-09
OPKO Health USD -27.82M 103.34M 2026-03
Organigram Holdings CAD -4.76M 10.02M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Pharma Mar EUR 2.71M 42.25M 2026-03
PTC Therapeutics USD -70.99M 91.62M 2025-12
Qiagen NV USD 249.69M 56.53M 2025-12
Regeneron Pharmaceuticals USD 1.2B 718.4M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sarepta Therapeutics USD -252.2M 84.16M 2025-12
Sartorius EUR 267.3M 10.1M 2026-03
Sino Biopharmaceutical CNY 2.59B 1.57B 2024-12
Tilray USD 8.36M 1.82M 2025-09
Ultragenyx Pharmaceutical USD -99.43M 57.35M 2025-12
Vertex Pharmaceuticals USD 1.19B 195.3M 2026-03
Zealand Pharma A/S -727.47M 285.54M 2025-12
Zhangzhou Pientzehuang Pharmaceutical CNY 882.7M 351.1M 2026-03